Combining proton and photon radiation to better target tumors and protect healthy tissue
Novel Optimization Methods and Treatment Planning System for Clinically-Deliverable Truly-Hybrid Proton-Photon Radiotherapy
This project builds treatment plans that mix proton and photon beams to more precisely hit tumors while sparing nearby organs for cancer patients who need radiotherapy.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ut Southwestern Medical Center NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project ID | NIH-11402098 on NIH RePORTER |
What this research studies
From the patient viewpoint, researchers are creating new computer methods that plan proton and photon radiation together instead of separately. They will build a treatment-planning system that finds the best mix of both beam types to improve tumor coverage and lower dose to organs at risk. The plans are designed so they can be delivered safely using existing proton and photon machines at treatment centers. The team will test the system with clinical cases and dosimetric comparisons to show how truly-hybrid plans differ from current approaches.
Who could benefit from this research
Good fit: Ideal candidates are cancer patients whose tumors are near critical organs and who can receive radiotherapy at centers that offer both proton and photon machines.
Not a fit: Patients whose cancers are already well controlled with standard photon- or proton-only therapy or who cannot access a center with both technologies may not experience extra benefit.
Why it matters
Potential benefit: If successful, this could mean better tumor control with fewer side effects by reducing radiation to healthy organs.
How similar studies have performed: Hybrid proton-photon approaches have been explored before using separate plans and show planning promise, but true joint optimization is a newer, less-tested approach with limited clinical evidence so far.
Where this research is happening
Dallas, United States
- Ut Southwestern Medical Center — Dallas, United States (Active)
Researchers
- Principal investigator: Gao, Hao — Ut Southwestern Medical Center
- Study coordinator: Gao, Hao
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.